Ureteral Stents Market
Report ID: SQMIG35A4195
Report ID: SQMIG35A4195
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A4195 |
Region:
Global |
Published Date: July, 2026
Pages:
157
|Tables:
146
|Figures:
78
Global Ureteral Stents Market size was valued at USD 530.0 Million in 2024 and is poised to grow from USD 562.86 Million in 2025 to USD 910.74 Million by 2033, growing at a CAGR of 6.2% during the forecast period (2026-2033).
The global ureteral stents market is a niche thing inside the wider urological devices arena, has moved along from those simple plastic tubes to much more advanced polymeric and biodegradable designs, which are meant to feel better for patients and lower complication chances. Now this shift is mostly pushed by the rising prevalence of urolithiasis and obstructive uropathies, and those get worse with aging demographics plus everyday lifestyle factors like not drinking enough water, and diet choices that aren’t ideal. At the same time, hospitals and outpatient clinics are leaning more into minimally invasive techniques, like ureteroscopy and percutaneous nephrolithotomy, so the need for dependable stenting solutions has basically increased a lot. Due to that, manufacturers keep funding R&D, and they chase regulatory approvals across North America, Europe, and also the increasingly active Asian markets. The market matters because it helps prevent renal damage, supports postoperative drainage, and boosts overall treatment results, so it becomes this key piece in contemporary urological care.
Moreover, building from all that, the biggest driver for the ureteral stents market growth is technological innovation, especially stuff that hits real clinical “pain points” directly. Think about drug‑eluting and bio‑resorbable stents that can release localized anti‑inflammatory agents while also removing the whole need for a later removal session. When these newer stents get used in practice, they’ve been linked to fewer hospital readmissions and quicker recovery schedules, and that makes things more cost‑effective for providers. It also encourages insurers to keep or expand reimbursement support. Beyond that, expanding endoscopic surgical activity in developing regions opens up additional distribution lanes, and device companies working with academic institutions help speed up clinical trial pipelines, so market access keeps broadening. In other words, it offers cause-and-effect rhythm where clinical demand, product sophistication, and economic incentives all reinforce each other, pushing sustained growth for ureteral stents.
AI-driven automation is changing the ureteral stents market outlook by making design, production, and quality control run smoother, like less wasted motion and fewer surprises. Machine learning models are helping forecast optimal stent geometry too, which cuts down the trial‑and‑error grind and speeds up time‑to‑market. On top of that, robotic assembly lines handle materials in a consistent way, lowering defect rates while freeing engineers to spend time on bigger improvements. Manufacturing equipment that’s full of data‑rich sensors can also deliver real time feedback, so operators can tune settings quickly, meaning inventories stay lean. For hospitals this can translate into quicker delivery of customized stents, which supports patient outcomes and helps the move toward personalized urology care. So overall, AI plus automation is building a supply chain that feels more responsive and more efficient, while also helping manufacturers differentiate in a competitive market.
Market snapshot - (2026-2033)
Global Market Size
USD 530.0 Million
Largest Segment
Polymer Stents
Fastest Growth
Metallic Stents
Growth Rate
6.2% CAGR
To get more insights on this market click here to Request a Free Sample Report
The global ureteral stents market is segmented by material type, application, stent design, end-user, distribution channel and region. Based on material type, the market is segmented into Polymer Stents, Metallic Stents and Others. Based on application, the market is segmented into Kidney Stones, Ureteral Strictures, Urinary Incontinence and Others. Based on stent design, the market is segmented into Double J Stents, Multiloop Stents and Others. Based on end-user, the market is segmented into Hospitals, Specialized Urology Centers, Ambulatory Surgical Centers and Others. Based on distribution channel, the market is segmented into Direct Institutional Sales, Medical Device Wholesalers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
As per the ureteral stents market analysis, the Polymer Stents end up being the dominant one because they feel naturally more flexible, show great biocompatibility, and generally cost less to make so clinicians prefer them for routine ureteral actions. In real practice, doctors like how they go in with less fuss, and patients often report less discomfort too. At the same time hospitals see the cost efficiency, especially when they’re handling high volume cases, so the whole procurement part becomes easier. This combination of broad acceptance, simple ordering, and the fact they can be adapted across different ureteral lengths and diameters locks polymer stents in as the market backbone.
However, Metallic Stents are starting to pull ahead faster, the momentum is strong, mostly due to progress with shape-memory alloys, which makes them self-expanding. That means positioning is easier, and there’s less worry about migration, at least compared with older designs. Urologists who want longer dwell time without swapping devices as often are paying attention, so the clinical use cases widen and manufacturers can tap into new revenue opportunities too.
According to the ureteral stents market forecast, the Kidney Stones segment stands out because most ureteral stent placements are tied to helping the stone move along and to prevent blockage after lithotripsy. Practitioners lean on the stents to keep urine flowing, lower post op discomfort, and reduce complications. That keeps demand steady across both normal schedules and emergency workflows. There’s also a clear protocol, plus reimbursement pathways that make the whole process smoother, so the segment keeps a central role in the market. And since minimally invasive options keep advancing, stenting continues being used as a supporting therapy rather than something that gets dropped.
Whereas the Ureteral Strictures segment looks like the fastest growing area right now. Newer drug‑eluting and biodegradable formats are better at handling chronic narrowing, and that’s changing surgeon choices. More surgeons are moving toward stents meant for prolonged patency, so repeat procedures can be reduced. This in turn boosts demand for more specialized devices and also pushes extra R&D, expanding where the market can go next.
To get detailed segments analysis, Request a Free Sample Report
As per the ureteral stents market regional forecast, North America keeps that edge mostly because the region has advanced health care infrastructure, a big take up of minimally invasive procedures, and reimbursement rules that push patients into faster access to new, smarter devices. There are strong research organizations too, plus this early technology mindset that helps products keep getting better, and also keeps clinical validation moving. Manufacturers don’t work alone either, they collaborate with major urology centers, and that helps build a steady stream of next generation stent design ideas. At the same time , solid distribution networks make it easier to reach patients in both city areas and rural places, so ureteral stents market penetration remains wide.
United States Ureteral Stents Market
In the United States, the ureteral stents sector benefits from a lot of clinical research work going on, which then supports quick integration of up to date technologies. Doctors often lean toward solutions that feel better for patients , and also lower complication rates, so performance matters here. Broad insurance coverage then makes utilization smoother across different care environments, which adds depth and resilience to the market.
Canada Ureteral Stents Market
In Canada, the ureteral stents industry is shaped by a publicly funded system that tends to choose cost effective therapies but only when they have solid clinical proof. Because evidence based practice is a real priority, adoption tends to favor stents with a proven safety history. Academic hospital networks share know how, and procurement is more streamlined, so reliable devices can keep showing up consistently across provinces.
Europe’s fast expansion is tied to regulated pathways that are more harmonized, so newer products can enter the market with less friction. Member states also push patient centered care, and health systems that feel more integrated make it easier for evidence driven technology to be adopted. Awareness of minimally invasive options is climbing too, and that supports demand. Plus, research initiatives across leading urology centers keep generating strong clinical data, which helps confidence in newer stent designs. On top of that, reimbursement frameworks that reward outcome improvements help maintain stable growth through the region.
Germany Ureteral Stents Market
The German ureteral stents market is supported by a long standing medical tradition, along with a strong record of clinical trial participation. Providers aim for high quality results, so they often prefer advanced stent materials and design enhancements. Physician networks , plus specialized urology clinics, spread best practices quickly, while reimbursement schemes that reflect value based care keep adoption steady across the country.
United Kingdom Ureteral Stents Market
In the United Kingdom the ureteral stents market is gaining momentum as clinicians increasingly adopt minimally invasive options that help patients recover sooner. National health service guidance leans toward cost effective interventions with proven impact, which encourages uptake of newer stent technologies. Ongoing cooperation between academic institutions and industry also speeds up evidence generation, and that sets the stage for continued expansion as clinicians try to improve procedural flow and patient satisfaction.
France Ureteral Stents Market
The French ureteral stents market is seeing swift growth, largely because clinicians actively advocate for innovative therapies. French health care professionals often focus on more personalized treatment pathways, and that supports demand for stents that improve comfort while lowering complication risk. Research consortia help produce high quality clinical insights, so next generation devices tend to get accepted faster across both public and private care settings.
Asia Pacific looks like it is getting stronger by, expanding healthcare capacity, boosting awareness around urological health, and pushing more funding into medical device innovation. In many countries of the region, hospitals are upgrading their infrastructure and leaning into minimally invasive techniques, and that keeps the appetite high for ureteral stents that can be trusted. When local makers team up with global innovators there is faster technology transfer too, and then training programs for clinicians—well they help raise practitioner know how. So all of that together, meaning infrastructure , education, and partnerships, it nudges the region into a bigger market role over time.
Japan Ureteral Stents Market
For Japan, the ureteral stents market does well because the overall medical ecosystem is mature, and it tends to care a lot about precision plus patient safety. Because of high expectations for device performance, stents that offer stronger biocompatibility and better handling, get taken up more readily. Also, ongoing professional development keeps urologists tuned in to new approaches, and that supports market steadiness while still allowing some steady domestic upgrades.
South Korea Ureteral Stents Market
In South Korea, the ureteral stents market is influenced by fast uptake of modern medical technologies and a clear stress on research excellence. Support from government for healthcare breakthroughs encourages collaboration between hospitals and device manufacturers, which then leads to the arrival of fresh stent options. At the same time patient preferences are shifting toward minimally invasive procedures, and that speeds up market momentum. Because of that, South Korea is becoming more of an active driver in regional growth.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Advancements in Minimally Invasive Techniques
Growing Geriatric Population Requiring Urological Care
High Cost of Advanced Stent Technologies
Regulatory Hurdles Across Regions
Request Free Customization of this report to help us to meet your business objectives.
The Ureteral Stents Market is competitive; there are leading players pushing product innovation, using biocompatible materials, and refining more advanced stent designs so patient comfort improves and complications go down a bit. A lot of companies are pouring money into research and development , while also doing strategic partnerships, mergers, acquisitions , plus geographic expansion to keep or grow their market presence. There’s also this rising focus on antimicrobial coatings, biodegradable stents, and minimally invasive urological procedures, which makes the rivalry stronger. At the same time, newer regional manufacturers are widening product accessibility , and in a way they’re starting to pressure the well known global players.
Top Player’s Company Profile
Recent Developments in the Ureteral Stents Market
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global ureteral stents market is propelled mostly by advances in minimally invasive techniques that improve procedural safety and encourage more stent usage. At the same time , the growing geriatric population plays a second role by raising demand for dependable urinary drainage. However, the high cost associated with advanced stent technologies acts like a brake on adoption in tighter, budget conscious health systems. North America currently leads the market, helped by advanced healthcare infrastructure, solid reimbursement support, and early uptake of new technology. Looking at product categories, polymer stents lead the segment , largely due to flexibility, biocompatibility, and cost efficiency, so they have become the backbone of procurement strategies worldwide.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 530.0 Million |
| Market size value in 2033 | USD 910.74 Million |
| Growth Rate | 6.2% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Ureteral Stents Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Ureteral Stents Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Ureteral Stents Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Ureteral Stents Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Ureteral Stents Market size was valued at USD 530.0 Million in 2024 and is poised to grow from USD 562.86 Million in 2025 to USD 910.74 Million by 2033, growing at a CAGR of 6.2% during the forecast period (2026-2033).
I’m unable to generate the requested content due to insufficient information. 'Boston Scientific', 'Cook Medical', 'C.R. Bard', 'Teleflex', 'Olympus', 'Coloplast', 'Medline Industries', 'Allium Medical', 'Applied Medical', 'GaltNeedleTech', 'B. Braun', 'PendraCare', 'Urotech', 'Optimed', 'Amecath', 'Urovision', 'Vogt Medical', 'Balton', 'Suru International', 'Purple Micro Port'
Advancements in minimally invasive techniques are expanding the indications for ureteral stent placement by enabling safer and more precise procedures. Clinicians are increasingly adopting endoscopic and image‑guided approaches that reduce patient discomfort and hospital stay, thereby encouraging broader utilization of stents. This clinical confidence supports higher procedure volumes and promotes integration of newer stent designs that complement these techniques, reinforcing market expansion through improved patient outcomes and procedural efficiency.
Minimally Invasive Expansion: The adoption of minimally invasive procedures is accelerating as clinicians prioritize patient comfort and faster recovery, driving demand for next‑generation ureteral stents that can be placed through tiny access ports. Innovations in delivery systems enable precise positioning, reducing operative time and complications. This shift is prompting manufacturers to redesign stent geometry and materials to align with endoscopic techniques, fostering partnerships with device firms specializing in urological scopes and reinforcing the market’s focus on procedural efficiency and enhanced patient outcomes significantly.
Why does North America Dominate the Global Ureteral Stents Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
